Wei Wang

TL;DR: In this paper, the relative contributions of metabolic syndrome (MetS) and dysglycemia on the risk of cardiovascular disease (CVD) have not been dissected, and the authors aimed to compare MetS with dys glycemia in their association with the 10-year incidence risk of CVD.

TL;DR: Assessment of the prevalence of the metabolic syndrome in the Chinese population using the ethnic-specific IDF and updated ATPIII criteria found thresholds for central obesity in different ethnic groups were identical for Asian populations.

TL;DR: MS with or without central obesity has a significantly increased 10-year risk of CVD in middle-aged Chinese, compared with other metabolic disorders of metabolic syndrome.

TL;DR: Among patients with ST-segment elevation myocardial infarction and multivessel disease who underwent primary PCI, an approach of staged complete revascularization is superior to culprit-only PCI at 5-year follow-up, Nevertheless, the advantage of staged PCI is attenuated in diabetic patients.

TL;DR: In patients with STEMI and multivessel disease, diabetes is not an independent predictor of adverse cardiovascular events at 5 years, whereas in nondiabetic patients, an approach of staged complete revascularization is superior to culprit-only PCI, whereas the advantage of staged PCI is attenuated in diabetic patients.